Erbitux gains expanded approval in Europe

August 1, 2008

Cetuximab (Erbitux) has received broader approval in the European Union as a first-line treatment for metastatic colorectal cancer. Erbitux can now be used in European patients with EGFR-expressing, KRAS wild-type metastatic colorectal cancer in combination with chemotherapy and also as a single agent in patients who have failed oxaliplatin(Drug information on oxaliplatin) (Eloxatin)-based and irinotecan(Drug information on irinotecan) (Camptosar)-based therapy, according to manufacturer Merck KGaA of Darmstadt, Germany.

European Commission approval was based on data from two randomized, controlled trials. In the phase III CRYSTAL study, patients with KRAS wild-type tumors had a 59% response rate with cetuximab(Drug information on cetuximab)/chemotherapy vs 43% for chemotherapy alone. In the phase II OPUS trial, response rates were 61% vs 37%, respectively.

TOPIC INDEX

More Topics

PUBLICATIONS


ONCOLOGY: Perspectives on Best Practices	ONCOLOGY: Nurse Edition	CANCER MANAGEMENT: A Multidisciplinary Approach

IMAGE IQ

Other than surgical interventions, which medication might be most appropriate for this patient?
	A 68-year-old woman presented with a mass on the scalp. An incisional biopsy of the scalp mass and an excisional biopsy of the lymph node both revealed basal cell carcinoma.

More Image IQs:

FROM PHYSICIANS PRACTICE

'What They Should Really Teach in Medical School'
Julie Schopps, MD , February 6, 2012
The North Carolina-based pediatrician weighs in on why she thinks the real learning doesn't take place until students are out of the classroom.

Improve EHR Systems by Rethinking Medical Billing
Daniel Essin, MA, MD, February 6, 2012
Separating billing-related data from other clinical documentation and transmitting it to a billing system is not difficult …no matter how the charting is done.

Keeping Your Medical Practice’s Accounts Receivable on Track
P.J. Cloud-Moulds, February 4, 2012
Here are the minimum reports you should be running to keep an eye on your practices A/R.

Healthcare Providers Play Crucial Role in Helping Victims of Abuse
Stephen Hanson, PA-C , February 3, 2012
I would urge each and every one of you to be familiar with the warning signs of abuse, and the resources available to you all as healthcare providers.

Protecting Your Medical Practice's Data
Marisa Torrieri, February 3, 2012
Here's the scoop on how to implement a good data-backup plan at your office.

Erbitux gains expanded approval in Europe

Join the Conversation